Skip to main content
. 2021 Apr 7;22(8):3819. doi: 10.3390/ijms22083819

Table 3.

Detailed information about patients included in this study.

Sample Age Menopausal Status Histological Type/Grade Limfovascular Invasion
(LVI)
FIGO Stage Depth of Miometrial Invasion Gradus HG/LG Gene Expression
qPCR
Protein
Levels
IHC
2 52 NA G1 * yes IA <50% L no yes §
3 65 postmenopausal G1 * no IA <50% L no yes
5 39 premenopausal dedifferentiated yes IB >50% H yes no
6 76 postmenopausal serous yes IIIC >50% H no yes §
7 50 premenopausal G1 * no IB Not present L yes yes §
8 83 postmenopausal dedifferentiated no IB >50% H yes no
9 41 premenopausal G1 * no IA <50% L yes yes
10 53 postmenopausal G1 * no IA not present L yes yes
11 60 postmenopausal G2 * yes IB >50% L no yes §
13 64 postmenopausal G1 * NA IV <50% L yes yes §
14 73 postmenopausal G1 * no IB >50% L yes yes §
15 64 postmenopausal G2 * yes IB >50% L no yes §
16 69 postmenopausal G1 * no IA <50% L yes yes §
18 79 postmenopausal G1 * no IB >50% L yes yes §
19 74 postmenopausal G1 * no IA <50% L yes yes
20 76 postmenopausal G1 * no IA <50% L yes yes §
21 53 premenopausal G2 * no IA not present L yes yes §
22 36 premenopausal G1 * no IA not present L no yes §
23 45 premenopausal G1 * no IA not present L yes yes §
24 69 postmenopausal G2 * yes IB >50% L yes yes §
25 54 premenopausal G3 * no IA <50% H yes yes
26 72 postmenopausal G1 * no IA <50% L yes yes
30 54 premenopausal G1 * no IA not present L yes yes §
31 69 postmenopausal G3 * yes IB >50% H no yes §
33 77 postmenopausal G3 * no IB >50% H yes yes §
34 57 postmenopausal mucinous, G1 * no IA <50% L yes yes §
35 61 postmenopausal G1 * no IA not present L no yes
38 78 postmenopausal G2 * yes IA <50% L no yes
39 63 postmenopausal G1 * yes IA <50% L no yes §
40 71 postmenopausal serous no IA <50% H yes yes §
44 73 postmenopausal serous yes IB >50% H yes yes §
46 50 premenopausal G2 * no IIIA <50% L no yes
47 27 premenopausal dedifferentiated no IA <50% H yes yes
48 59 postmenopausal serous yes IB >50% H no yes §
49 70 postmenopausal G1 * no IA <50% L yes yes
50 73 postmenopausal G1 * no IA <50% L yes yes §
51 75 postmenopausal G2 * yes IA <50% L yes yes §
52 75 postmenopausal G2 * yes IA <50% L yes yes §
53 50 postmenopausal G3 * yes IA <50% H yes yes §
54 71 postmenopausal G1 * no IA <50% L yes yes
55 75 postmenopausal serous yes IIIC >50% H no yes §
56 55 postmenopausal G1 * no IA not present L yes yes
57 43 premenopausal G1 * no IA not present L yes yes
58 68 postmenopausal G2 * no IA <50% L no yes §
60 55 postmenopausal G1 * no IA not present L no yes §
61 83 postmenopausal G1 * no IA not present L no yes
62 59 postmenopausal G1 * no IA not present L yes yes
63 66 postmenopausal G1 * no IA <50% L yes yes
64 66 postmenopausal G1 * no IA <50% L no yes
65 80 postmenopausal carcinosarcoma yes IB >50% H yes yes §
66 72 postmenopausal G1 * no IA <50% L yes yes §
68 45 premenopausal G1 * no II <50% L yes yes §
69 72 postmenopausal G1 * no IA <50% L no yes §
70 55 postmenopausal G3 * NA IB >50% H no yes
71 48 premenopausal serous no IA <50% H yes yes

§ samples where only tumour or only control tissue was included in TMA (i.e., not paired samples), * endometrioid.